We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Warning Letter to Bronchoscope Maker Lymol Medical
FDA Issues Warning Letter to Bronchoscope Maker Lymol Medical
Devicemaker Lymol Medical FDA received a warning letter from the FDA for failure to validate cleaning and sterilization processes, among other GMP failures, uncovered during an inspection of its Woburn, Massachusetts facility.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor